These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 33955200)

  • 61. Prevention of excessive collagen accumulation by human intravenous immunoglobulin treatment in a murine model of bleomycin-induced scleroderma.
    Kajii M; Suzuki C; Kashihara J; Kobayashi F; Kubo Y; Miyamoto H; Yuuki T; Yamamoto T; Nakae T
    Clin Exp Immunol; 2011 Feb; 163(2):235-41. PubMed ID: 21091669
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Inhibitory effect of kaempferol on skin fibrosis in systemic sclerosis by the suppression of oxidative stress.
    Sekiguchi A; Motegi SI; Fujiwara C; Yamazaki S; Inoue Y; Uchiyama A; Akai R; Iwawaki T; Ishikawa O
    J Dermatol Sci; 2019 Oct; 96(1):8-17. PubMed ID: 31447184
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Oligosaccharide modification by N-acetylglucosaminyltransferase-V in macrophages are involved in pathogenesis of bleomycin-induced scleroderma.
    Kato A; Yutani M; Terao M; Kimura A; Itoi S; Murota H; Miyoshi E; Katayama I
    Exp Dermatol; 2015 Aug; 24(8):585-90. PubMed ID: 25876794
    [TBL] [Abstract][Full Text] [Related]  

  • 64. ACSL4 inhibition prevents macrophage ferroptosis and alleviates fibrosis in bleomycin-induced systemic sclerosis model.
    Cao D; Zheng J; Li Z; Yu Y; Chen Z; Wang Q
    Arthritis Res Ther; 2023 Oct; 25(1):212. PubMed ID: 37884942
    [TBL] [Abstract][Full Text] [Related]  

  • 65. DNA from macrophages induces fibrosis and vasculopathy through POLR3A/STING/type I interferon axis in systemic sclerosis.
    Liu C; Tang J; Luo W; Liu S; Sun X; Hong W; Zhou X; Lu J; Li M; Zhu L
    Rheumatology (Oxford); 2023 Feb; 62(2):934-945. PubMed ID: 35686918
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Suppressive Regulation by MFG-E8 of Latent Transforming Growth Factor β-Induced Fibrosis via Binding to αv Integrin: Significance in the Pathogenesis of Fibrosis in Systemic Sclerosis.
    Fujiwara C; Uehara A; Sekiguchi A; Uchiyama A; Yamazaki S; Ogino S; Yokoyama Y; Torii R; Hosoi M; Suto C; Tsunekawa K; Murakami M; Ishikawa O; Motegi SI
    Arthritis Rheumatol; 2019 Feb; 71(2):302-314. PubMed ID: 30175895
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Spleen tyrosine kinase (Syk) inhibitor fostamatinib limits tissue damage and fibrosis in a bleomycin-induced scleroderma mouse model.
    Pamuk ON; Can G; Ayvaz S; Karaca T; Pamuk GE; Demirtas S; Tsokos GC
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S15-22. PubMed ID: 26148346
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Interleukin-13-producing CD8+ T cells mediate dermal fibrosis in patients with systemic sclerosis.
    Fuschiotti P; Larregina AT; Ho J; Feghali-Bostwick C; Medsger TA
    Arthritis Rheum; 2013 Jan; 65(1):236-46. PubMed ID: 23001877
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Overexpression of TIM-3 in Macrophages Aggravates Pathogenesis of Pulmonary Fibrosis in Mice.
    Wang Y; Kuai Q; Gao F; Wang Y; He M; Zhou H; Han G; Jiang X; Ren S; Yu Q
    Am J Respir Cell Mol Biol; 2019 Dec; 61(6):727-736. PubMed ID: 31162951
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Inhibition of skin fibrosis in systemic sclerosis by botulinum toxin B via the suppression of oxidative stress.
    Baral H; Sekiguchi A; Uchiyama A; Nisaa Amalia S; Yamazaki S; Inoue Y; Yokoyama Y; Ogino S; Torii R; Hosoi M; Akai R; Iwawaki T; Ishikawa O; Motegi SI
    J Dermatol; 2021 Jul; 48(7):1052-1061. PubMed ID: 33840125
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Regulation of pulmonary inflammation and fibrosis through expression of integrins alphaVbeta3 and alphaVbeta5 on pulmonary T lymphocytes.
    Luzina IG; Todd NW; Nacu N; Lockatell V; Choi J; Hummers LK; Atamas SP
    Arthritis Rheum; 2009 May; 60(5):1530-9. PubMed ID: 19404954
    [TBL] [Abstract][Full Text] [Related]  

  • 72. B cells in systemic sclerosis: a possible target for therapy.
    Bosello S; De Luca G; Tolusso B; Lama G; Angelucci C; Sica G; Ferraccioli G
    Autoimmun Rev; 2011 Aug; 10(10):624-30. PubMed ID: 21545850
    [TBL] [Abstract][Full Text] [Related]  

  • 73. RGC32 Promotes Bleomycin-Induced Systemic Sclerosis in a Murine Disease Model by Modulating Classically Activated Macrophage Function.
    Sun C; Chen SY
    J Immunol; 2018 Apr; 200(8):2777-2785. PubMed ID: 29507108
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Inhibitory Regulation of Skin Fibrosis in Systemic Sclerosis by Apelin/APJ Signaling.
    Yokoyama Y; Sekiguchi A; Fujiwara C; Uchiyama A; Uehara A; Ogino S; Torii R; Ishikawa O; Motegi SI
    Arthritis Rheumatol; 2018 Oct; 70(10):1661-1672. PubMed ID: 29676521
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A novel bispecific antibody alleviates bleomycin-induced systemic sclerosis injury.
    Yin Q; Pi X; Ren G; Liu Z; Liu H; Wang M; Hu C; Zhao H; Li D; Yin J
    Int Immunopharmacol; 2020 Aug; 85():106644. PubMed ID: 32474387
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Generation of a novel CD30
    Higashioka K; Kikushige Y; Ayano M; Kimoto Y; Mitoma H; Kikukawa M; Akahoshi M; Arinobu Y; Horiuchi T; Akashi K; Niiro H
    Clin Exp Immunol; 2020 Sep; 201(3):233-243. PubMed ID: 32538493
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Blockade of IL-11 Trans-Signaling or JAK2/STAT3 Signaling Ameliorates the Profibrotic Effect of IL-11.
    Ye W; Wang Q; Zhao L; Wang C; Zhang D; Zhou M; Chen F; Wang W; Zhu Z; Guo W; Liu Y; Zou H; Xue Y
    Immunol Invest; 2023 Nov; 52(6):703-716. PubMed ID: 37401665
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Type 2 innate lymphoid cell counts are increased in patients with systemic sclerosis and correlate with the extent of fibrosis.
    Wohlfahrt T; Usherenko S; Englbrecht M; Dees C; Weber S; Beyer C; Gelse K; Distler O; Schett G; Distler JH; Ramming A
    Ann Rheum Dis; 2016 Mar; 75(3):623-6. PubMed ID: 26338035
    [TBL] [Abstract][Full Text] [Related]  

  • 79. 2-Methoxyestradiol inhibits bleomycin-induced systemic sclerosis through suppression of fibroblast activation.
    Zhu L; Song Y; Li M
    J Dermatol Sci; 2015 Jan; 77(1):63-70. PubMed ID: 25465161
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Surfactant protein-D regulates effector cell function and fibrotic lung remodeling in response to bleomycin injury.
    Aono Y; Ledford JG; Mukherjee S; Ogawa H; Nishioka Y; Sone S; Beers MF; Noble PW; Wright JR
    Am J Respir Crit Care Med; 2012 Mar; 185(5):525-36. PubMed ID: 22198976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.